Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?

References

• Alessi DR, Sakamoto K, Bayascas JR. (2006). LKB1-dependent signalling pathways. Annu Rev Biochem 75:137–63.
   PubMed Web of Science ®Google Scholar
• Asante-Appiah E, Kennedy BP. (2003). Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am J Physiol Endocrinol Metab 284:E663–70.
   PubMed Web of Science ®Google Scholar
• Baas AF, Boudeau J, Sapkota GP, Smit L, Medema R, Morrice NA, Alessi DR, Clevers HC. (2003). Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J 22:3062–72.
   PubMed Web of Science ®Google Scholar
• Bastie CC, Zong H, Xu J, Busa B, Judex S, Kurland IJ, Pessin JE. (2007). Integrative metabolic regulation of peripheral tissue fatty acid oxidation by the SRC kinase family member Fyn. Cell Metab 5:371–81.
   PubMed Web of Science ®Google Scholar
• Boggon TJ, Eck MJ. (2004). Structure and regulation of Src family kinases. Oncogene 23:7918–27.
   PubMed Web of Science ®Google Scholar
• Boudeau J, Baas AF, Deak M, Morrice NA, Kieloch A, Schutkowski M, Prescott AR, Clevers HC, Alessi DR. (2003). MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J 22:5102–14.
   PubMed Web of Science ®Google Scholar
• Brown MT, Cooper JA. (1996). Regulation, substrates and functions of src. Biochim Biophys Acta 1287:121–49.
   PubMed Web of Science ®Google Scholar
• Bull HA, Brickell PM, Dowd PM. (1994). Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells. FEBS Lett 351: 41–4.
   PubMed Web of Science ®Google Scholar
• Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, Williams TM, Brasaemle DL, Jelicks LA, Scherer PE, Kim JK, Lisanti MP. (2005). Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol 288:C1317–31.
   PubMed Web of Science ®Google Scholar
• Chan AC, Desai DM, and Weiss A. (1994). The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu Rev Immunol 12:555–92.
   PubMed Web of Science ®Google Scholar
• Chong YP, Ia KK, Mulhern TD, and Cheng HC. (2005a). Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases. Biochim Biophys Acta 1754:210–20.
   PubMed Web of Science ®Google Scholar
• Chong YP, Mulhern TD, Cheng HC. (2005b). C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)-endogenous negative regulators of Src-family protein kinases. Growth Factors 23:233–44.
   PubMed Web of Science ®Google Scholar
• Chong YP, Mulhern TD, Zhu HJ, Fujita DJ, Bjorge JD, Tantiongco JP, Sotirellis N, Lio DS, Scholz G, Cheng HC. (2004). A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity. J Biol Chem 279:20752–66.
   PubMed Web of Science ®Google Scholar
• Choudhury GG, Mahimainathan L, Das F, Venkatesan B, and Ghosh-Choudhury N. (2006). c-Src couples PI 3 kinase/Akt and MAPK signalling to PDGF-induced DNA synthesis in mesangial cells. Cell Signal 18:1854–64.
   PubMed Web of Science ®Google Scholar
• Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. (2008a). The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230–33.
   PubMed Web of Science ®Google Scholar
• Christofk HR, Vander Heiden MG, Wu N, Asara JM, and Cantley LC. (2008b). Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452:181–6.
   PubMed Web of Science ®Google Scholar
• Chung AB, Stepien G, Haraguchi Y, Li K, Wallace DC. (1992). Transcriptional control of nuclear genes for the mitochondrial muscle ADP/ATP translocator and the ATP synthase beta subunit. Multiple factors interact with the OXBOX/REBOX promoter sequences. J Biol Chem 267:21154–61.
   PubMed Web of Science ®Google Scholar
• Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, Lisanti MP. (2003). Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 285:C222–35.
   PubMed Web of Science ®Google Scholar
• Collins SP, Reoma JL, Gamm DM, Uhler MD. (2000). LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem J 345 Pt 3:673–80.
   PubMed Web of Science ®Google Scholar
• Colognato H, Ramachandrappa S, Olsen IM, ffrench-Constant C. (2004). Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol 167:365–75.
   PubMed Web of Science ®Google Scholar
• Cooke MP, Perlmutter RM. (1989). Expression of a novel form of the fyn proto-oncogene in hematopoietic cells. New Biol 1:66–74.
   PubMedGoogle Scholar
• Davies SP, Hawley SA, Woods A, Carling D, Haystead TA, Hardie DG. (1994). Purification of the AMP-activated protein kinase on ATP-gamma-sepharose and analysis of its subunit structure. Eur J Biochem 223:351–7.
   PubMedGoogle Scholar
• Davies SP, Helps NR, Cohen PT, Hardie DG. (1995). 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC. FEBS Lett 377:421–5.
   PubMed Web of Science ®Google Scholar
• Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ. (1997). Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem 272:19125–32.
   PubMed Web of Science ®Google Scholar
• Drover VA, Abumrad NA. (2005). CD36-dependent fatty acid uptake regulates expression of peroxisome proliferator activated receptors. Biochem Soc Trans 33:311–15.
   PubMed Web of Science ®Google Scholar
• Ebert BL, Firth JD, Ratcliffe PJ. (1995). Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem 270:29083–9.
   PubMed Web of Science ®Google Scholar
• Gadue P, Yin L, Jain S, Stein PL. (2004). Restoration of NK T cell development in fyn-mutant mice by a TCR reveals a requirement for Fyn during early NK T cell ontogeny. J Immunol 172:6093–100.
   PubMed Web of Science ®Google Scholar
• Goldsmith JF, Hall CG, Atkinson TP. (2002). Identification of an alternatively spliced isoform of the fyn tyrosine kinase. Biochem Biophys Res Commun 298:501–4.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Hawley SA. (2001). AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23:1112–19.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Salt IP, Hawley SA, Davies SP. (1999). AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 338 (Pt 3):717–22.
   PubMedGoogle Scholar
• Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG. (2003). Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2:28.
   PubMedGoogle Scholar
• Hawley SA, Gadalla AE, Olsen GS, Hardie DG. (2002). The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51:2420–5.
   PubMed Web of Science ®Google Scholar
• Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG. (2005). Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2:9–19.
   PubMed Web of Science ®Google Scholar
• Hawley SA, Selbert MA, Goldstein EG, Edelman AM, Carling D, Hardie DG. (1995). 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J Biol Chem 270:27186–91.
   PubMed Web of Science ®Google Scholar
• Huang MM, Bolen JB, Barnwell JW, Shattil SJ, Brugge JS. (1991). Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. Proc Natl Acad Sci USA 88: 7844–8.
   PubMed Web of Science ®Google Scholar
• Kajita K, Mune T, Ikeda T, Matsumoto M, Uno Y, Sugiyama C, Matsubara K, Morita H, Takemura M, Seishima M, Takeda J, Ishizuka T. (2008). Effect of fasting on PPARgamma and AMPK activity in adipocytes. Diabetes Res Clin Pract 81:144–9.
   PubMed Web of Science ®Google Scholar
• Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR. (2003). Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 278:39422–7.
   PubMed Web of Science ®Google Scholar
• Lage R, Dieguez C, Vidal-Puig A, Lopez M. (2008). AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 14:539–49.
   PubMed Web of Science ®Google Scholar
• Liang X, Lu Y, Wilkes M, Neubert TA, Resh MD. (2004). The N-terminal SH4 region of the Src family kinase Fyn is modified by methylation and heterogeneous fatty acylation: role in membrane targeting, cell adhesion, and spreading. J Biol Chem 279:8133–9.
   PubMed Web of Science ®Google Scholar
• Liang X, Nazarian A, Erdjument-Bromage H, Bornmann W, Tempst P, Resh MD. (2001). Heterogeneous fatty acylation of Src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction. J Biol Chem 276:30987–94.
   PubMed Web of Science ®Google Scholar
• Luttrell LM, Daaka Y, Lefkowitz RJ. (1999). Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 11:177–83.
   PubMed Web of Science ®Google Scholar
• Marley AE, Sullivan JE, Carling D, Abbott WM, Smith GJ, Taylor IW, Carey F, Beri RK. (1996). Biochemical characterization and deletion analysis of recombinant human protein phosphatase 2C alpha. Biochem J 320 (Pt 3):801–6.
   PubMedGoogle Scholar
• Mastick CC, Saltiel AR. (1997). Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. J Biol Chem 272:20706–14.
   PubMed Web of Science ®Google Scholar
• Meex SJ, van der Kallen CJ, van Greevenbroek MM, Eurlings PM, El Hasnaoui M, Evelo CT, Lindsey PJ, Luiken JJ, Glatz JF, de Bruin TW. (2005). Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia. FASEB J 19:2063–5.
   PubMed Web of Science ®Google Scholar
• Momcilovic M, Hong SP, Carlson M. (2006). Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem 281:25336–43.
   PubMed Web of Science ®Google Scholar
• Muller G, Wied S, Frick W. (2000). Cross talk of pp125(FAK) and pp59(Lyn) non-receptor tyrosine kinases to insulin-mimetic signalling in adipocytes. Mol Cell Biol 20:4708–23.
   PubMed Web of Science ®Google Scholar
• Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H. (1991). Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nature 351:69–72.
   PubMed Web of Science ®Google Scholar
• Newcomb LF, Mastick CC. (2002). Src family kinase-dependent phosphorylation of a 29-kDa caveolin-associated protein. Biochem Biophys Res Commun 290:1447–53.
   PubMed Web of Science ®Google Scholar
• Oshikawa J, Otsu K, Toya Y, Tsunematsu T, Hankins R, Kawabe J, Minamisawa S, Umemura S, Hagiwara Y, Ishikawa Y. (2004). Insulin resistance in skeletal muscles of caveolin-3-null mice. Proc Natl Acad Sci USA 101:12670–75.
   PubMed Web of Science ®Google Scholar
• Parravicini V, Gadina M, Kovarova M, Odom S, Gonzalez-Espinosa C, Furumoto Y, Saitoh S, Samelson LE, O’Shea JJ, Rivera J. (2002). Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 3:741–8.
   PubMed Web of Science ®Google Scholar
• Perez MJ, Ortiz EH, Roffe M, Soto EF, Pasquini JM. (Forthcoming). Fyn kinase is involved in oligodendroglial cell differentiation induced by apotransferrin. J Neurosci Res.
   Web of Science ®Google Scholar
• Picard C, Gilles A, Pontarotti P, Olive D, Collette Y. (2002). Cutting edge: recruitment of the ancestral fyn gene during emergence of the adaptive immune system. J Immunol 168:2595–8.
   PubMed Web of Science ®Google Scholar
• Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, Jennings IG, Campbell DJ, Witters LA, Parker MW, Kemp BE, Stapleton D. (2003). AMPK beta subunit targets metabolic stress sensing to glycogen. Curr Biol 13:867–71.
   PubMed Web of Science ®Google Scholar
• Poole AW, Jones ML. (2005). A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell Signal 17:1323–32.
   PubMed Web of Science ®Google Scholar
• Pravenec M, Landa V, Zidek V, Musilova A, Kazdova L, Qi N, Wang J, St Lezin E, Kurtz TW. (2003). Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiol Res 52:681–8.
   PubMed Web of Science ®Google Scholar
• Rafaeloff-Phail R, Ding L, Conner L, Yeh WK, McClure D, Guo H, Emerson K, Brooks H. (2004). Biochemical regulation of mammalian AMP-activated protein kinase activity by NAD and NADH. J Biol Chem 279:52934–9.
   PubMed Web of Science ®Google Scholar
• Roskoski Jr. R. (2005). Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 331:1–14.
   PubMed Web of Science ®Google Scholar
• Salt I, Celler JW, Hawley SA, Prescot, A, Woods A, Carling D, Hardie DG. (1998). AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem J 334 (Pt 1):177–87.
   PubMedGoogle Scholar
• Saltiel AR, Pessin JE. (2002). Insulin signalling pathways in time and space. Trends Cell Biol 12:65–71.
   PubMed Web of Science ®Google Scholar
• Saltiel AR, Pessin JE. (2003). Insulin signalling in microdomains of the plasma membrane. Traffic 4:711–716.
   PubMed Web of Science ®Google Scholar
• Sapkota GP, Kieloch A, Lizcano JM, Lain S, Arthur JS, Williams MR, Morrice N, Deak M, Alessi DR. (2001). Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP- dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell growth. J Biol Chem 276:19469–82.
   PubMed Web of Science ®Google Scholar
• Sato I, Obata Y, Kasahara K, Nakayama Y, Fukumoto Y, Yamasaki T, Yokoyama KK, Saito T, Yamaguchi N. (2009). Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain. J Cell Sci 122:965–75.
   PubMed Web of Science ®Google Scholar
• Sefton BM, Taddie JA. (1994). Role of tyrosine kinases in lymphocyte activation. Curr Opin Immunol 6:372–9.
   PubMed Web of Science ®Google Scholar
• Sekimoto H, Boney CM. (2003). C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signalling through Src in 3T3-L1 differentiation. Endocrinology 144:2546–52.
   PubMed Web of Science ®Google Scholar
• Sfeir Z, Ibrahimi A, Amri E, Grimaldi P, Abumrad N. (1999). CD36 antisense expression in 3T3-F442A preadipocytes. Mol Cell Biochem 192:3–8.
   PubMed Web of Science ®Google Scholar
• Shulman GI. (2000). Cellular mechanisms of insulin resistance. J Clin Invest 106:171–6.
   PubMed Web of Science ®Google Scholar
• Sicheri F, Kuriyan J. (1997). Structures of Src-family tyrosine kinases. Curr Opin Struct Biol 7:777–85.
   PubMed Web of Science ®Google Scholar
• Sim AT, Hardie DG. (1988). The low activity of acetyl-CoA carboxylase in basal and glucagon-stimulated hepatocytes is due to phosphorylation by the AMP-activated protein kinase and not cyclic AMP-dependent protein kinase. FEBS Lett 233:294–8.
   PubMed Web of Science ®Google Scholar
• Stapleton D, Gao G, Michell BJ, Widmer J, Mitchelhill K, Teh T, House CM, Witters LA, Kemp BE. (1994). Mammalian 5′-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J Biol Chem 269:29343–6.
   PubMed Web of Science ®Google Scholar
• Sudol M, Greulich H, Newman L, Sarkar A, Sukegawa J, Yamamoto T. (1993). A novel Yes-related kinase, Yrk, is expressed at elevated levels in neural and hematopoietic tissues. Oncogene 8:823–31.
   PubMed Web of Science ®Google Scholar
• Sun Y, Ma YC, Huang J, Chen KY, McGarrigle DK, Huang XY. (2005). Requirement of SRC-family tyrosine kinases in fat accumulation. Biochemistry 44:14455–62.
   PubMed Web of Science ®Google Scholar
• Takeuchi M, Kuramochi S, Fusaki N, Nada S, Kawamura-Tsuzuku J, Matsuda S, Semba K, Toyoshima K, Okada M, Yamamoto T. (1993). Functional and physical interaction of protein-tyrosine kinases Fyn and Csk in the T-cell signalling system. J Biol Chem 268:27413–19.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, Watanabe M, Magoori K, Ioka RX, Tachibana K, Watanabe Y, Uchiyama Y, Sumi K, Iguchi H, Ito S, Doi T, Hamakubo T, Naito M, Auwerx J, Yanagisawa M, Kodama T, Sakai J. (2003). Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 100:15924–9.
   PubMed Web of Science ®Google Scholar
• van’t Hof W, Resh MD. (1997). Rapid plasma membrane anchoring of newly synthesized p59fyn: selective requirement for NH2-terminal myristoylation and palmitoylation at cysteine-3. J Cell Biol 136:1023–35.
   PubMed Web of Science ®Google Scholar
• Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferre P, Foufelle F, Carling D. (2000). Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20:6704–11.
   PubMed Web of Science ®Google Scholar
• Woods A, Cheung PC, Smith FC, Davison MD, Scott J, Beri RK, Carling D. (1996a). Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. J Biol Chem 271:10282–90.
   PubMed Web of Science ®Google Scholar
• Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D. (2005). Ca2+/ calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2:21–33.
   PubMed Web of Science ®Google Scholar
• Woods A, Salt I, Scott J, Hardie DG, Carling D. (1996b). The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 397:347–51.
   PubMed Web of Science ®Google Scholar
• Wu Y, Song P, Xu J, Zhang M, Zou MH. (2007). Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J Biol Chem 282:9777–88.
   Google Scholar
• Wullschleger S, Loewith R, Hall MN. (2006). TOR signalling in growth and metabolism. Cell 124:471–84.
   PubMed Web of Science ®Google Scholar
• Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, Mann DL, Taffet GE, Baldini A, Khoury DS, Schneider MD. (2006). A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci USA 103:17378–83.
   PubMed Web of Science ®Google Scholar
• Zheng XM, Resnick RJ, Shalloway D. (2000). A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. EMBO J 19:964–78.
   PubMed Web of Science ®Google Scholar